Metsera will use its IPO proceeds to fund the Phase III development of its injectable, ultra-long-acting GLP-1 therapy MET-097i, which last week achieved 11.3% weight loss in a Phase IIa study
OnceWeekly Subcutaneous Injection: Convenient singledose pen that can be administered any time of day, with or without food, on the same day each week
It is, uh, very much going through an algorithm in our minds of what is this person's risk factors
Lifting weights, using resistance bands, or doing bodyweight exercises preserves muscle mass during weight loss
Enzymes such as sortases, butelases, trypsiligases, and engineered variants of subtilisins like omniligases, subtiligases, and peptiligases have been employed for peptide fragment ligation, with significantly advancing CEPS
Another person added: This feels dystopian. Speaking to The Independent , Sara said she first saw the ad on 42nd street, but that she has since seen the adverts on the turnstiles and boards at smaller stations as well